Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-23 12:19 pm Purchase | 2025-01-15 | 13G | Silexion Therapeutics Ltd. SLXN | CVI Investments, Inc. | 339,000 8.500% | 339,000 (New Position) | Filing History |
| 2025-01-13 10:47 am Purchase | 2025-01-06 | 13G | Microbot Medical Inc. MBOT | CVI Investments, Inc. | 1,257,143 6.100% | 1,257,143 (New Position) | Filing History |
| 2025-01-13 09:52 am Purchase | 2025-01-03 | 13G | Bionano Genomics, Inc. BNGO | CVI Investments, Inc. | 10,700,000 7.700% | 10,700,000 (New Position) | Filing History |
| 2025-01-10 7:36 pm Purchase | 2025-01-02 | 13G | Alset EHome International Inc. AEI | CVI Investments, Inc. | 750,000 7.000% | 750,000 (New Position) | Filing History |
| 2025-01-07 10:09 am Purchase | 2024-12-28 | 13G | Snow Lake Resources Ltd. LITM | CVI Investments, Inc. | 384,615 6.500% | 384,615 (New Position) | Filing History |
| 2024-12-26 2:19 pm Purchase | 2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO | CVI Investments, Inc. | 109,298 7.300% | 109,298 (New Position) | Filing History |
| 2024-12-26 2:15 pm Purchase | 2024-12-18 | 13G | Gaxos.ai Inc. GXAI | CVI Investments, Inc. | 507,247 9.100% | 507,247 (New Position) | Filing History |
| 2024-12-23 11:30 am Purchase | 2024-12-16 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | CVI Investments, Inc. | 3,333,332 7.200% | 3,333,332 (New Position) | Filing History |
| 2024-12-17 12:30 pm Purchase | 2024-12-13 | 13G | Candel Therapeutics, Inc. CADL | CVI Investments, Inc. | 2,350,000 5.600% | 2,350,000 (New Position) | Filing History |
| 2024-12-12 11:50 am Purchase | 2024-12-04 | 13G | Colombier Acquisition Corp. CLBR | CVI Investments, Inc. | 3,010,000 7.600% | 3,010,000 (New Position) | Filing History |
| 2024-12-05 10:15 am Purchase | 2024-11-26 | 13G | Rigetti Computing, Inc. RGTI | CVI Investments, Inc. | 25,000,000 8.900% | 25,000,000 (New Position) | Filing History |
| 2024-11-27 10:15 am Purchase | 2024-11-22 | 13G | Autonomix Medical, Inc. Common Stock AMIX | CVI Investments, Inc. | 193,972 9.900% | 193,972 (New Position) | Filing History |
| 2024-11-14 12:25 pm Purchase | 2024-09-30 | 13G | Ryvyl Inc. RVYL | CVI Investments, Inc. | 746,727 9.900% | 150,592 (+25.26%) | Filing History |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | Galmed Pharmaceuticals Ltd. GLMD | CVI Investments, Inc. | 167,258 9.900% | 167,258 (New Position) | Filing History |
| 2024-11-14 12:23 pm Sale | 2024-09-30 | 13G | NOGIN INC NOGNQ | CVI Investments, Inc. | 0 0.000% | -1,252,857 (Position Closed) | Filing History |
| 2024-11-14 12:22 pm Purchase | 2024-09-30 | 13G | RedHill Biopharma Ltd. RDHL | CVI Investments, Inc. | 672,549,217 4.900% | 672,549,217 (New Position) | Filing History |
| 2024-11-14 12:21 pm Unchanged | 2024-09-30 | 13G | Tenax Therapeutics, Inc. TENX | CVI Investments, Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-14 12:19 pm Sale | 2024-09-30 | 13G | RENALYTIX PLC ADS RNLXY | CVI Investments, Inc. | 3,865,342 2.300% | -4,682,446 (-54.78%) | Filing History |
| 2024-11-14 12:19 pm Unchanged | 2024-09-30 | 13G | Protara Therapeutics, Inc. TARA | CVI Investments, Inc. | 600,380 2.800% | 0 (Unchanged) | Filing History |
| 2024-11-14 12:18 pm Sale | 2024-09-30 | 13G | Azitra, Inc. AZTR | CVI Investments, Inc. | 400,526 4.900% | -209,474 (-34.34%) | Filing History |